These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29544679)

  • 1. Molecular bases of the poor response of liver cancer to chemotherapy.
    Marin JJG; Briz O; Herraez E; Lozano E; Asensio M; Di Giacomo S; Romero MR; Osorio-Padilla LM; Santos-Llamas AI; Serrano MA; Armengol C; Efferth T; Macias RIR
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):182-192. PubMed ID: 29544679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
    Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
    Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresistance and chemosensitization in cholangiocarcinoma.
    Marin JJG; Lozano E; Herraez E; Asensio M; Di Giacomo S; Romero MR; Briz O; Serrano MA; Efferth T; Macias RIR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1444-1453. PubMed ID: 28600147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Bases of Chemoresistance in Cholangiocarcinoma.
    Marin JJG; Lozano E; Briz O; Al-Abdulla R; Serrano MA; Macias RIR
    Curr Drug Targets; 2017; 18(8):889-900. PubMed ID: 25706108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to enhance the response of liver cancer to pharmacological treatments.
    Marin JJG; Macias RIR; Asensio M; Romero MR; Temprano AG; Pereira OR; Jimenez S; Mauriz JL; Di Giacomo S; Avila MA; Efferth T; Briz O
    Am J Physiol Cell Physiol; 2024 Jul; 327(1):C11-C33. PubMed ID: 38708523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion.
    Gonzalez-Sanchez E; Marin JJ; Perez MJ
    Mol Pharm; 2014 Jun; 11(6):1856-68. PubMed ID: 24824514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 gene silencing in pediatric epithelial liver tumors.
    Warmann SW; Frank H; Heitmann H; Ruck P; Herberts T; Seitz G; Fuchs J
    J Surg Res; 2008 Jan; 144(1):43-8. PubMed ID: 17574594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Hepatobiliary Cancers.
    Nault JC; Villanueva A
    Hepatology; 2021 Jan; 73 Suppl 1():115-127. PubMed ID: 32045030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
    Yang S; Wang XQ
    BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.
    Marin JJG; Macias RIR; Monte MJ; Romero MR; Asensio M; Sanchez-Martin A; Cives-Losada C; Temprano AG; Espinosa-Escudero R; Reviejo M; Bohorquez LH; Briz O
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
    Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects.
    Lei YR; He XL; Li J; Mo CF
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):52. PubMed ID: 38420802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma.
    Nooron N; Ohba K; Takeda K; Shibahara S; Chiabchalard A
    Tohoku J Exp Med; 2017 Aug; 242(4):291-302. PubMed ID: 28794318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
    Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y
    Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.